RMC No. 5-2022: FDA-Endorsed Updates to VAT-Exempt Products List for Medicines and Health Items

RMC No. 5-2022 republishes the FDA-endorsed updates to VAT-exempt products, affecting businesses handling medicines for kidney diseases. Immediate compliance is required. Businesses handling medicines for kidney diseases and related health products must update their VAT exemption practices immediately. RMC No. 5-2022 republishes the Food and Drug Administration’s letter endorsing updates to the list of VAT-exempt […]

RMC No. 103-2021: Updated List of VAT-Exempt Medicines and COVID-19 Drugs for Immediate Compliance

RMC No. 103-2021 publishes updated VAT-exempt lists of medicines for hypertension, cancer, kidney diseases, and COVID-19 drugs, requiring immediate compliance for affected businesses. Businesses and taxpayers dealing with pharmaceutical products and COVID-19 treatments must immediately review the updated VAT-exempt lists published by the FDA and DOH. This update, under RMC No. 103-2021, supplements prior guidelines […]

RR No. 4-2021: CREATE Act VAT Exemptions, 1% Percentage Tax Rate, and Transition Rules for Non-VAT Taxpayers

RR No. 4-2021 implements CREATE Act VAT exemptions, the P3M VAT threshold, 1% percentage tax, and transition rules for non-VAT taxpayers. Businesses must immediately review whether their sales, imports, receipts, invoices, and input VAT treatment changed under the CREATE Act because RR No. 4-2021 implements major VAT and percentage tax amendments affecting real estate sales, […]